Priser
Platform
Blog
Om os
Download
301501
Hefei Hengxin Life Science & Technology Co
Shenzhen Stock Exchange
0

Om

Hefei Hengxin Life Science Co. Ltd. is a company engaged in the development and commercialization of healthcare products in China. Specializing in the life sciences sector, the company focuses on producing innovative medical devices and pharmaceutical products that support health and wellness. Operating within a rapidly growing industry, Hefei Hengxin Life Science Co. Ltd. has made significant contributions to biotechnology and healthcare technology markets. The company leverages advanced research and development capabilities to address unmet medical needs and enhance the quality of life for individuals globally. By prioritizing highly technical and specialized solutions, Hefei Hengxin Life Science Co. Ltd. plays an essential role in advancing medical solutions and improving healthcare outcomes across various demographics. Its commitment to scientific excellence and patient care is recognized through its partnerships and collaborations within the healthcare and pharmaceutical sectors.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HEFEI HENGXIN LIFE SCIENCE & TECHNOLOGY CO MED ENDAVU: Køb Hefei Hengxin Life Science & Technology Co ($301501) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hefei Hengxin Life Science & Technology Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker301501
Land
Kina
Hjemmesidehfhxin.com
SektorForbrug - cyklisk
IndustriEmballage og beholdere

Udbytter

0,24CNH
'25
Ex-udbytte-dato6. jun. 2025
Udbytteafkast0%